Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview.
Curr Mol Med
; 21(5): 385-391, 2021.
Article
Dans Anglais
| MEDLINE | ID: covidwho-789058
ABSTRACT
COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Antiviraux
/
Quercétine
/
Type d'étude:
Étude observationnelle
/
Étude pronostique
Limites du sujet:
Humains
langue:
Anglais
Revue:
Curr Mol Med
Thème du journal:
Biologie moléculaire
Année:
2021
Type de document:
Article
Pays d'affiliation:
1566524020999200918150630
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS